Skip to main content
Clinical Trials/NL-OMON30394
NL-OMON30394Not yet recruitingNot Applicable

The development and evaluation of a behavioural program to treat drooling in children wit Cerebral Palsy - Behaviour therapy for drooling in CP

Sint Maartenskliniek0 sites20 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • · a confirmed diagnosis of CP, with detailed descriptions of movement impairment;
  • · drooling severity: Teacher Drool Scale (TDS: Camp-Bruno et al., 1989) score 3 (occasional drooling; intermittent all day) or more (4: frequent drooling; but not profuse; 5: constant drooling; always wet);
  • · developmental age >= 6 years; the child displays reasonable awareness of the practical and/or social consequences of drooling;
  • · the child has the ability to close his/her mouth and swallow on demand;
  • · the child has the ability to remain seated (or is able to correct seating position independently);
  • · the child has the ability to wipe the mouth/chin;
  • · the child is susceptible to social and/or material reinforcers;
  • · medication to treat drooling stopped at least 3 months before inclusion;
  • · the parents and teachers are willing to participate in the treatment program, i.e. to perform activities to maintain the training effect.
  • · the child and their parents and teachers are willing to participate in scientific research, including activities for data-collection (informed consent is obtained) and if significant positive changes are established are prepared to refrain from other medical treatment for 6 months after the end of the training.

Exclusion Criteria

  • · the child has uncontrollable (epileptic) seizures;
  • · the child has severe aggressive or hyperactive behaviour;
  • · during 6 months before inclusion there has been surgery or botulinum toxin injection

Investigators

Similar Trials